73 related articles for article (PubMed ID: 20423656)
1. [The detection of anti-nuclear antibody and IL-21 in patients infected with hepatitis C virus].
Zou M; Li MM; Huang SB; Li XJ; Zhou YP; Liu SW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):471-2. PubMed ID: 20423656
[TBL] [Abstract][Full Text] [Related]
2. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of antinuclear antibody in hepatitis C virus infection.
Peng YC; Hsieh SC; Yang DY; Tung CF; Hu WH; Huang WN; Chen GH
J Clin Gastroenterol; 2001; 33(5):402-6. PubMed ID: 11606858
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
6. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
7. Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response.
Khairy M; El-Raziky M; El-Akel W; Abdelbary MS; Khatab H; El-Kholy B; Esmat G; Mabrouk M
Liver Int; 2013 Nov; 33(10):1504-9. PubMed ID: 23763380
[TBL] [Abstract][Full Text] [Related]
8. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
[TBL] [Abstract][Full Text] [Related]
10. The liver profile in patients with hepatitis C virus and/or fascioliasis.
Wahib AA; el-Nasr MS; Mangoud AM; el-Shazly AM; Morsy AT
J Egypt Soc Parasitol; 2006 Aug; 36(2):405-40. PubMed ID: 16927859
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
12. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
[TBL] [Abstract][Full Text] [Related]
13. Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients.
Lukic R; Gajovic N; Jovanovic I; Jurisevic M; Mijailovic Z; Maric V; Popovska Jovicic B; Arsenijevic N
Dis Markers; 2017; 2017():6275987. PubMed ID: 28487598
[TBL] [Abstract][Full Text] [Related]
14. Changes in liver enzymes after surgery in anti-hepatitis C virus-positive patients.
Murakami S; Okubo K; Tsuji Y; Sakata H; Takahashi T; Kikuchi M; Hirayama R
World J Surg; 2004 Jul; 28(7):671-4. PubMed ID: 15175902
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of autoantibody, anti-HCV and anti-HIV seropositivities in "anti-HBc alone" positive samples].
Meşe S; Ozekinci T; Yilmaz S; Atmaca S; Arikan E
Mikrobiyol Bul; 2006 Jul; 40(3):269-74. PubMed ID: 17001858
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
Kaşifoğlu N; Us T; Akgün Y
Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
[TBL] [Abstract][Full Text] [Related]
17. Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients.
Taghinejad A; Barani S; Gholijani N; Ghandehari F; Khansalar S; Asadipour M; Davarpanah M; Fattahi M; Kalantar K
Eur Cytokine Netw; 2020 Dec; 31(4):134-139. PubMed ID: 33648921
[TBL] [Abstract][Full Text] [Related]
18. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
Batchoun RG; Al-Najdawi MA; Al-Taamary S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients.
Hsieh MY; Dai CY; Lee LP; Huang JF; Chuang WL; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML
Kaohsiung J Med Sci; 2012 Feb; 28(2):86-93. PubMed ID: 22313535
[TBL] [Abstract][Full Text] [Related]
20. Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.
Nelson DR; Soldevila-Pico C; Reed A; Abdelmalek MF; Hemming AW; Van der Werf WJ; Howard R; Davis GL
Liver Transpl; 2001 Dec; 7(12):1064-70. PubMed ID: 11753908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
